$548 Million is the total value of Ikarian Capital, LLC's 139 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -306 | -100.0% | 0.00% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -99 | -100.0% | 0.00% | – | |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -830 | -100.0% | -0.00% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -1,990 | -100.0% | -0.00% | – |
| PDSB | Exit | PDS BIOTECHNOLOGY CORP | $0 | – | -3,672 | -100.0% | -0.00% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -2,292 | -100.0% | -0.00% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -128,454 | -100.0% | -0.00% | – |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -18,975 | -100.0% | -0.01% | – |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -5,456 | -100.0% | -0.01% | – | |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -1,587 | -100.0% | -0.01% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,882 | -100.0% | -0.01% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -37,248 | -100.0% | -0.01% | – |
| ATNX | Exit | ATHENEX INC | $0 | – | -80,039 | -100.0% | -0.01% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -1,362 | -100.0% | -0.01% | – |
| CMPX | Exit | COMPASS THERAPEUTICS INC | $0 | – | -74,171 | -100.0% | -0.01% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -155,606 | -100.0% | -0.01% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -5,428 | -100.0% | -0.02% | – |
| GOSS | Exit | GOSSAMER BIO INCput | $0 | – | -14,900 | -100.0% | -0.02% | – |
| GMDA | Exit | GAMIDA CELL LTD | $0 | – | -32,689 | -100.0% | -0.02% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -106,952 | -100.0% | -0.02% | – | |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -49,843 | -100.0% | -0.02% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -29,644 | -100.0% | -0.02% | – |
| KOD | Exit | KODIAK SCIENCES INCcall | $0 | – | -25,700 | -100.0% | -0.03% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -37,017 | -100.0% | -0.03% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -12,124 | -100.0% | -0.03% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -257,883 | -100.0% | -0.03% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -71,856 | -100.0% | -0.03% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -206,336 | -100.0% | -0.03% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -108,933 | -100.0% | -0.04% | – |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -22,552 | -100.0% | -0.04% | – |
| ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -210,182 | -100.0% | -0.04% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -476,625 | -100.0% | -0.04% | – |
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -52,177 | -100.0% | -0.04% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -9,640 | -100.0% | -0.05% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -1,289,130 | -100.0% | -0.05% | – |
| VLON | Exit | VALLON PHARMACEUTICALS INC | $0 | – | -201,758 | -100.0% | -0.05% | – |
| Exit | NEUROSENSE THERAPEUTICS LTDordinary shares | $0 | – | -100,000 | -100.0% | -0.05% | – | |
| OCUP | Exit | OCUPHIRE PHARMA INC | $0 | – | -124,021 | -100.0% | -0.05% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -159,390 | -100.0% | -0.06% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOLOGIES | $0 | – | -412,293 | -100.0% | -0.06% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -227,076 | -100.0% | -0.06% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -68,100 | -100.0% | -0.07% | – |
| VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -742,980 | -100.0% | -0.07% | – |
| DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -221,252 | -100.0% | -0.07% | – |
| Exit | AVALO THERAPEUTICS INC | $0 | – | -764,271 | -100.0% | -0.07% | – | |
| KOD | Exit | KODIAK SCIENCES INCput | $0 | – | -73,100 | -100.0% | -0.07% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INCcall | $0 | – | -800,000 | -100.0% | -0.08% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -21,801 | -100.0% | -0.08% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -39,730 | -100.0% | -0.08% | – |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -527,462 | -100.0% | -0.08% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -117,009 | -100.0% | -0.08% | – |
| Exit | TENAX THERAPEUTICS INC | $0 | – | -735,097 | -100.0% | -0.08% | – | |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -521,155 | -100.0% | -0.08% | – |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -511,186 | -100.0% | -0.08% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -90,805 | -100.0% | -0.08% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -349,468 | -100.0% | -0.08% | – |
| NKTR | Exit | NEKTAR THERAPEUTICScall | $0 | – | -133,900 | -100.0% | -0.10% | – |
| QSI | Exit | QUANTUM SI INC | $0 | – | -157,363 | -100.0% | -0.10% | – |
| PBLA | Exit | PANBELA THERAPEUTICS INC | $0 | – | -355,959 | -100.0% | -0.10% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -77,274 | -100.0% | -0.10% | – |
| CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -510,126 | -100.0% | -0.11% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INCput | $0 | – | -1,200,000 | -100.0% | -0.11% | – |
| CABA | Exit | CABALETTA BIO INCcall | $0 | – | -449,000 | -100.0% | -0.12% | – |
| Exit | MAXCYTE INC | $0 | – | -137,958 | -100.0% | -0.13% | – | |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -8,763 | -100.0% | -0.14% | – |
| CASI | Exit | CASI PHARMACEUTICALS INC | $0 | – | -1,320,155 | -100.0% | -0.14% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -78,550 | -100.0% | -0.14% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -87,071 | -100.0% | -0.14% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -213,310 | -100.0% | -0.15% | – |
| ACET | Exit | ADICET BIO INCcall | $0 | – | -62,100 | -100.0% | -0.16% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -164,119 | -100.0% | -0.19% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -49,997 | -100.0% | -0.23% | – |
| LQDA | Exit | LIQUIDIA CORPORATION | $0 | – | -243,904 | -100.0% | -0.23% | – |
| INBX | Exit | INHIBRX INCcall | $0 | – | -85,800 | -100.0% | -0.25% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.27% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.27% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.28% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -1,622,552 | -100.0% | -0.28% | – |
| ZLAB | Exit | ZAI LAB LTDcall | $0 | – | -53,100 | -100.0% | -0.31% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -47,408 | -100.0% | -0.45% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INCcall | $0 | – | -160,700 | -100.0% | -0.50% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCput | $0 | – | -106,600 | -100.0% | -0.62% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -20,000 | -100.0% | -0.64% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -217,915 | -100.0% | -0.92% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -60,000 | -100.0% | -0.94% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -249,907 | -100.0% | -1.09% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -202,203 | -100.0% | -1.23% | – |
| GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -181,300 | -100.0% | -1.42% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -181,300 | -100.0% | -1.42% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCcall | $0 | – | -264,700 | -100.0% | -1.53% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELcall | $0 | – | -100,000 | -100.0% | -2.36% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -478,784 | -100.0% | -2.76% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCput | $0 | – | -649,600 | -100.0% | -2.80% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -429,600 | -100.0% | -5.30% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -935,600 | -100.0% | -11.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.